|
Delayed
Nasdaq Stockholm
07:03:24 19/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 9.000 SEK | -0.11% |
|
+3.81% | -33.33% |
| 13/08 | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 13/08 | Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 9.98Cr 1.05Cr 90.38L 85.04L 77.29L 1.45Cr 100.27Cr 1.48Cr 3.91Cr 50Cr 3.93Cr 3.84Cr 167.04Cr | P/E 2026 * |
-2.99x | P/E 2027 * | -2.49x |
|---|---|---|---|---|---|
| Enterprise Value | 9.18Cr 96.25L 83.14L 78.22L 71.09L 1.34Cr 92Cr 1.36Cr 3.6Cr 46Cr 3.61Cr 3.54Cr 153.64Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | -0.11% | ||
| 1 week | +3.81% | ||
| Current month | +7.40% | ||
| 1 month | +2.27% | ||
| 3 months | +7.14% | ||
| 6 months | +8.04% | ||
| Current year | -33.33% |
| 1 week | 8.5 |  | 9.14 |
| 1 month | 7.6 | | 9.14 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 27.3 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/03/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/03/22 | Others | Chairman | 1,20,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 22,50,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.11% | +3.81% | -62.50% | -62.58% | 1.05Cr | |
| +3.56% | +4.11% | +80.67% | +130.98% | 1,09300Cr | |
| +1.16% | +4.90% | +53.90% | +63.51% | 65TCr | |
| +1.86% | +5.99% | +27.87% | +75.58% | 46TCr | |
| +1.59% | +0.30% | +40.89% | +44.16% | 35TCr | |
| +1.04% | +2.11% | +25.69% | +40.91% | 29TCr | |
| +2.24% | +3.26% | +2.56% | +13.21% | 25TCr | |
| +3.55% | +5.70% | +48.84% | +68.73% | 23TCr | |
| +1.05% | +0.03% | -13.92% | -52.49% | 20TCr | |
| +2.70% | +8.59% | +25.05% | +94.28% | 18TCr | |
| Average | +1.88% | +1.34% | +22.91% | +41.63% | 37.1TCr | |
| Weighted average by Cap. | +2.29% | +1.45% | +46.26% | +73.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.1Cr -32.52L -28.09L -26.43L -24.02L -45.18L -31Cr -45.84L -1.21Cr -16Cr -1.22Cr -1.19Cr -52Cr | -4Cr -41.96L -36.24L -34.1L -30.99L -58.29L -40Cr -59.15L -1.57Cr -20Cr -1.58Cr -1.54Cr -67Cr |
| Net Debt | -80L -8L -7L -7L -6L -11.66L -8.04Cr -11.83L -31.35L -4.02Cr -31.51L -30.83L -13Cr | -1.7Cr -17.83L -15.4L -14.49L -13.17L -24.77L -17Cr -25.14L -66.62L -8.55Cr -66.96L -65.5L -28Cr |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | SEK 9.000 | -0.11% | 13,420 |
| 18/26/18 | SEK 9.010 | +3.33% | 43,456 |
| 17/26/17 | SEK 8.720 | -2.90% | 10,595 |
| 14/26/14 | SEK 8.980 | -0.11% | 1,575 |
| 13/26/13 | SEK 8.990 | +3.69% | 26,950 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
